Panel to finalise cancer drugs for 30% trade margin cap; Rs 2,500 crore annual savings possible
An expert group is finalizing the list of cancer medicines for a new trade margin cap. The government plans to implement a 30% cap to reduce drug prices and save patients money. Retail prices of some anti-cancer drugs could drop by up to 70% as a result of this cap.
The trade margin rationalisation will apply to all cancer medicines, including branded and generic versions.
Read the full report on The Economic Times
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- The Economic Times
- Reporter
- teena thacker
- Published
- Tuesday, 13 October 2026, 1:40 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from The Economic Times with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
